Performance History

Key Stats
Open	$70.31
Prev. Close	$70.38
EPS	2.59
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	69.96	70.90
52 Week Range	58.93	96.12

Ratios







EPS	2.59

Score Breakdown

There's no data available for score breakdown

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Edwards Lifesciences (EW)

Edwards Lifesciences Corp (EW) is a global leader in advanced medical technologies, specializing in the development and manufacturing of heart valve systems and hemodynamic monitoring devices. The company's products are designed to treat patients with structural heart disease, as well as those in critical care settings. With a strong commitment to innovation and patient-centric solutions, Edwards Lifesciences Corp has revolutionized the field of cardiovascular care.

The stock price history of Edwards Lifesciences Corp reflects its success and growth. Over the years, the company has consistently delivered strong financial performance, driving the stock price higher. Investors have benefited from its steady appreciation and potential for long-term growth. The company's stock has experienced significant volatility at times, reflecting the inherent risks associated with the healthcare industry. However, Edwards Lifesciences Corp has consistently demonstrated its ability to overcome challenges and deliver value to its shareholders.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Bernard J. Zovighian
Headquarters: Irvine
Employees: 17300
Exchange: NYSE

Keep an eye on Edwards Lifesciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Edwards Lifesciences's (EW) price per share?

The current price per share for Edwards Lifesciences (EW) is $70.48. The stock has seen a price change of $0.09 recently, indicating a 0.13% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Edwards Lifesciences (EW)?

For Edwards Lifesciences (EW), the 52-week high is $96.12, which is 36.38% from the current price. The 52-week low is $58.93, the current price is 19.6% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Edwards Lifesciences (EW) a growth stock?

Edwards Lifesciences (EW) has shown an average price growth of -4.13% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Edwards Lifesciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Edwards Lifesciences (EW) stock price performance year to date (YTD)?

As of the latest data, Edwards Lifesciences (EW) has a year-to-date price change of -6.74%. Over the past month, the stock has experienced a price change of -0.18%. Over the last three months, the change has been -0.56%. Over the past six months, the figure is -19.41%. Looking at a longer horizon, the five-year price change stands at -13.61%.

help

Is Edwards Lifesciences (EW) a profitable company?

Edwards Lifesciences (EW) has a net income of $1.4B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 77.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 29.11% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $6B, with a revenue growth rate of 11.56%, providing insight into the company's sales performance and growth. The gross profit is $4.62B. Operating income is noted at $1.53B. Furthermore, the EBITDA is $1.79B.

help

What is the market capitalization of Edwards Lifesciences (EW)?

Edwards Lifesciences (EW) has a market capitalization of $41.57B. The average daily trading volume is 70.43, indicating the stock's liquidity and investor engagement.

News

EDWARDS LIFESCIENCES CORPORATION

CLASS ACTION LAWSUIT

SECURITIES

TRANSCATHETER AORTIC VALVE REPLACEMENT

Nov 23, 2024

EW ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Edwards Lifesciences Corporation

EDWARDS LIFESCIENCES CORPORATION

SECURITIES CLASS ACTION

TAVR

Nov 22, 2024

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW

EDWARDS LIFESCIENCES CORPORATION

TAVR

CLASS ACTION LAWSUIT

Nov 19, 2024

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – EW

DEADLINE ALERT for AILE, IREN, EW, AIXI: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

EDWARDS LIFESCIENCES CORPORATION

SECURITIES FRAUD

CLASS ACTION LAWSUIT

TRANSCATHETER AORTIC VALVE REPLACEMENT

Nov 17, 2024

Kessler Topaz Meltzer & Check, LLP Notifies Edwards Lifesciences Corporation Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit

EW FRAUD ALERT: Suffer Losses on Your Edwards Lifesciences Securities? Contact BFA Law before December 13 Securities Fraud Class Action Deadline (NYSE:EW)

Performance History

Score Breakdown

Analyst Forecast

Analyst Ratings

About Edwards Lifesciences (EW)

Keep an eye on Edwards Lifesciences

Frequently Asked Questions

What is Edwards Lifesciences's (EW) price per share?

What is the 52-week high and low for Edwards Lifesciences (EW)?

Is Edwards Lifesciences (EW) a growth stock?

What is Edwards Lifesciences (EW) stock price performance year to date (YTD)?

Is Edwards Lifesciences (EW) a profitable company?

What is the market capitalization of Edwards Lifesciences (EW)?

News

Take Your Investments to a Whole New Level